File this under better late than never, the visual abstract for last night and tonight's #NephJC is here!
Thiazide induced hyponatremia is this week's version of spooky sodium. Here's the visual abstract.
This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?
This week, we will discuss the HOPE trial - no not that one - the one in dialysis that was a LBCT in 2024. Should we look beyond analgesics to non-pharmacological options more seriously?
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every big nephrology congress. Probably 1st place won’t surprise anyone; it was the anticipated FLOW of the year, but this Top 10 Nephrology Stories definitely includes some unexpected titles
This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
File this under better late than never, the visual abstract for last night and tonight's #NephJC is here!
Thiazide induced hyponatremia is this week's version of spooky sodium. Here's the visual abstract.
The recent CJASN data from DOPPS, also links to two excellent videos from the NHS Heart of England centre. They are a first person account, giving a vivid example of the change that simple itching can have in all aspects of day to day life.
The Visual Abstract for the ACTIVE trial NephJC, scheduled for Tuesday/Wednesday this week. From the Visual Abstract artist, @KidneyBea_n
Apart from the storify and transcript, don't miss the commentary from Rodby, and this summary from Paul Welling:
#nephjc A few final thoughts: pic.twitter.com/XdUZK1Z5K0
— Paul A Welling (@PaulAWelling1) June 7, 2017
Thanks again to the ISPD, PDI and Daniel Schwartz from ISPD/Vancouver for setting this up & publicizing